Gold, Linda Stein, Jonathan S Weiss, Lawrence Green, Leon Kircik, Lauren Miller, Abby Jacobson, and Susan Harris. “Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Baseline Body Surface Area of 6 -12%”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s37. Accessed July 21, 2024.